Patient engagement is a crucial aspect of patient-centered drug development, as it seeks to involve patients as active participants in the decision-making processes related to their healthcare. By actively engaging patients in drug development, researchers and healthcare professionals can gain valuable insights into patient preferences, needs, and experiences, ultimately leading to more effective and patient-centered treatment options. Through initiatives such as patient advisory boards, focus groups, and surveys, patients are given a platform to share their perspectives on potential therapies, clinical trial designs, and outcome measures. This collaboration helps ensure that drug development efforts align with patient values and priorities, thus improving the quality of care provided. By placing the patient at the center of the drug development process, stakeholders can work together toward developing treatments that are not only safe and effective but also tailored to meet the unique needs of individual patients.